RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause

During menopausal transition, decreased level of estrogen brings a number of physiological problems and hormonal changes. In this study, promoter methylation of RANKL and FSHR genes were identified in 30 premenopausal and 35 postmenopausal women using methylation-specific high resolution melting (MS...

Full description

Bibliographic Details
Main Authors: Kalkan R, Altarda M, Tosun O
Format: Article
Language:English
Published: Sciendo 2020-08-01
Series:Balkan Journal of Medical Genetics
Subjects:
Online Access:https://doi.org/10.2478/bjmg-2020-0001
_version_ 1797718662350635008
author Kalkan R
Altarda M
Tosun O
author_facet Kalkan R
Altarda M
Tosun O
author_sort Kalkan R
collection DOAJ
description During menopausal transition, decreased level of estrogen brings a number of physiological problems and hormonal changes. In this study, promoter methylation of RANKL and FSHR genes were identified in 30 premenopausal and 35 postmenopausal women using methylation-specific high resolution melting (MS-HRM) analysis. The statistical analyses and their association with patient characteristics were performed by Pearson χ2 and Fisher’s exact test (p <0.05). The methylated RANKL gene was detected in 16 postmenopausal cases, and 12 (75.0%) of the RANKL methylated cases had hot flashes (p = 0.024). The methylated FSHR gene was detected in 18 postmenopausal cases, and 13 (75.0%) of the methylated cases had hot flashes (p = 0.028). In vitro studies demonstrated the association between RANKL expression, FSH level and hot flashes in the mouse. Although lack of epigenetic studies in this field proves our results crucial and therefore, our results showed magnitude of epigenetic profiles of Turkish Cypriot post-menopausal women. This was the first study which has investigated the RANKL and FSHR methylation and their relationship with hot flashes in postmenopausal women.
first_indexed 2024-03-12T08:53:39Z
format Article
id doaj.art-38e2e853164648b992cafcdc4bbb68dd
institution Directory Open Access Journal
issn 1311-0160
language English
last_indexed 2024-03-12T08:53:39Z
publishDate 2020-08-01
publisher Sciendo
record_format Article
series Balkan Journal of Medical Genetics
spelling doaj.art-38e2e853164648b992cafcdc4bbb68dd2023-09-02T16:10:17ZengSciendoBalkan Journal of Medical Genetics1311-01602020-08-01231515610.2478/bjmg-2020-0001bjmg-2020-0001RANKL is a new epigenetic biomarker for the vasomotor symptom during MenopauseKalkan R0Altarda M1Tosun O2Department of Medical Genetics, Faculty of Medicine, Near East University, Nicosia, Turkish Republic of Northern CyprusDepartment of Medical Genetics, Faculty of Medicine, Near East University, Nicosia, Turkish Republic of Northern CyprusDepartment of Biostatistics, Faculty of Medicine, Near East University, Nicosia, Turkish Republic of Northern CyprusDuring menopausal transition, decreased level of estrogen brings a number of physiological problems and hormonal changes. In this study, promoter methylation of RANKL and FSHR genes were identified in 30 premenopausal and 35 postmenopausal women using methylation-specific high resolution melting (MS-HRM) analysis. The statistical analyses and their association with patient characteristics were performed by Pearson χ2 and Fisher’s exact test (p <0.05). The methylated RANKL gene was detected in 16 postmenopausal cases, and 12 (75.0%) of the RANKL methylated cases had hot flashes (p = 0.024). The methylated FSHR gene was detected in 18 postmenopausal cases, and 13 (75.0%) of the methylated cases had hot flashes (p = 0.028). In vitro studies demonstrated the association between RANKL expression, FSH level and hot flashes in the mouse. Although lack of epigenetic studies in this field proves our results crucial and therefore, our results showed magnitude of epigenetic profiles of Turkish Cypriot post-menopausal women. This was the first study which has investigated the RANKL and FSHR methylation and their relationship with hot flashes in postmenopausal women.https://doi.org/10.2478/bjmg-2020-0001epigeneticsfshrrankl geneshot flashesmenopause
spellingShingle Kalkan R
Altarda M
Tosun O
RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause
Balkan Journal of Medical Genetics
epigenetics
fshr
rankl genes
hot flashes
menopause
title RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause
title_full RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause
title_fullStr RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause
title_full_unstemmed RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause
title_short RANKL is a new epigenetic biomarker for the vasomotor symptom during Menopause
title_sort rankl is a new epigenetic biomarker for the vasomotor symptom during menopause
topic epigenetics
fshr
rankl genes
hot flashes
menopause
url https://doi.org/10.2478/bjmg-2020-0001
work_keys_str_mv AT kalkanr ranklisanewepigeneticbiomarkerforthevasomotorsymptomduringmenopause
AT altardam ranklisanewepigeneticbiomarkerforthevasomotorsymptomduringmenopause
AT tosuno ranklisanewepigeneticbiomarkerforthevasomotorsymptomduringmenopause